Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.

Journal article

Tipoe T. et al, (2022), Current opinion in HIV and AIDS, 17, 162 - 170

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Journal article

Tomic A. et al, (2022), Nature communications, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Journal article

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV

Journal article

Ogbe A. et al, (2022), JCI Insight

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Human MAIT cells respond to and suppress HIV-1.

Journal article

Phetsouphanh C. et al, (2021), eLife, 10

Immunotherapeutic approaches to HIV cure and remission

Journal article

Lee MJ. et al, (2021), Current Opinion in Infectious Diseases, Publish Ahead of Print

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Journal article

Townsend A. et al, (2021), Nature Communications, 12

Load More